Adamas Biotech
Lecce · Founded 2018
About Adamas Biotech
Adamas Biotech develops clinically validated, nutraceutical-based prophylactic and therapeutic solutions for clinical and wellness indications. They offer evidence-based medicine and access to the scientific methods integral to creating innovative solutions in the nutraceutical field. Through their unique scientific-nutraceutical approach, they utilize raw materials with clinically validated biological activities. They provide antioxidant, anti-angiogenic, and anti-inflammatory properties of green tea extracts for the treatment of high-grade intraepithelial neoplasia and for blocking its progression into prostate cancer.
Company Facts
- Founded: 2018
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $968.5K
- Last round: Grant (Aug 2024)
- Website: https://www.adamasbiotech.it
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Pharmaceutical, Wellness
Social Profiles
Canonical: https://fsome.com/organization/adamas-biotech-52093 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.